NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 350 filers reported holding NATERA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $946,950 | -89.3% | 21,400 | -88.2% | 0.00% | -91.3% |
| Q2 2023 | $8,846,388 | -50.3% | 181,800 | -43.3% | 0.02% | -50.0% |
| Q1 2023 | $17,788,608 | -33.7% | 320,400 | -52.0% | 0.05% | -38.7% |
| Q4 2022 | $26,813,475 | -25.8% | 667,500 | -19.1% | 0.08% | -28.6% |
| Q3 2022 | $36,152,000 | -5.0% | 825,000 | -23.2% | 0.10% | -2.8% |
| Q2 2022 | $38,063,000 | -19.6% | 1,074,000 | -7.8% | 0.11% | -14.3% |
| Q1 2022 | $47,364,000 | +539.5% | 1,164,300 | +1368.2% | 0.13% | +563.2% |
| Q4 2021 | $7,406,000 | -64.5% | 79,300 | -57.6% | 0.02% | -64.8% |
| Q3 2021 | $20,862,000 | -64.5% | 187,200 | -63.8% | 0.05% | -65.2% |
| Q2 2021 | $58,718,000 | -1.6% | 517,200 | -12.0% | 0.16% | -5.5% |
| Q1 2021 | $59,685,000 | +25.9% | 587,800 | +23.4% | 0.16% | +29.1% |
| Q4 2020 | $47,391,000 | +30.4% | 476,200 | -5.3% | 0.13% | +22.1% |
| Q3 2020 | $36,329,000 | +17.8% | 502,900 | -18.7% | 0.10% | +14.3% |
| Q2 2020 | $30,838,000 | +74.1% | 618,500 | +4.2% | 0.09% | +33.8% |
| Q1 2020 | $17,716,000 | +52.0% | 593,300 | +71.5% | 0.07% | +151.9% |
| Q4 2019 | $11,653,000 | +78.5% | 345,900 | +73.8% | 0.03% | +68.8% |
| Q3 2019 | $6,527,000 | -0.8% | 199,000 | -16.6% | 0.02% | 0.0% |
| Q2 2019 | $6,578,000 | +38.5% | 238,500 | +3.5% | 0.02% | +33.3% |
| Q1 2019 | $4,751,000 | +105.4% | 230,400 | +39.0% | 0.01% | +100.0% |
| Q4 2018 | $2,313,000 | -23.7% | 165,700 | +30.8% | 0.01% | -14.3% |
| Q3 2018 | $3,033,000 | +47.4% | 126,700 | +15.9% | 0.01% | +16.7% |
| Q2 2018 | $2,057,000 | – | 109,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |